Journal

Journal of the American Heart Association

Papers (2)

Blood Pressure, Cardiometabolic Traits, and Cardiovascular Events in Women With Uterine Fibroids: A Genetic Correlation and Mendelian Randomization Study

Background Uterine fibroids (UFs) are understudied uterus neoplasms, mainly affecting women of reproductive age and often leading to hysterectomy. Clinical series suggest impaired cardiometabolic features in UFs. We investigated potential genetic links between blood pressure (BP), several cardiometabolic traits, and UFs. Methods and Results We used summary statistics of genome‐wide association studies for UFs and 18 traits related to BP, obesity, lipids, and main vascular diseases. We applied linkage disequilibrium score regression to estimate genetic correlations and Genome‐Wide Complex Trait Analysis‐multitrait‐based conditional and joint analysis to perform adjusted correlations. Univariate and bidirectional Mendelian randomization verified potential causal associations with UFs. We found UFs to significantly correlate with systolic BP (genetic correlation coefficient [r g ]=0.08, P =8.7×10 −5 ) and diastolic BP (r g =0.12, P =8.2×10 −8 ), including after adjustment for body mass index. UFs also positively corelated with body mass index (r g =0.11, P =4.1×10 −4 ), waist‐to‐hip ratio (r g =0.09, P =7.3×10 −3 ), type 2 diabetes (r g =0.15, P =1.9×10 −5 ), and triglycerides (r g =0.17, P =7.6×10 −7 ). We identified a negative correlation with sex hormone‐binding globulin (r g =−0.16, P =3×10 −4 ), a marker of bioavailability of sex steroids. No evidence for shared genetic basis with vascular diseases was observed, except with migraine (r g =0.08, P =5.8×10 −7 ). Mendelian randomization analyses confirmed higher body mass index to increase UF risk (beta‐per‐kg/m 2 =0.033, P =6.1×10 −5 ), as did waist‐to‐hip ratio (beta‐per‐unit=0.193, P =3.3×10 −5 ) and triglycerides (bet‐per‐mmol/L=0.163, P =1.9×10 −5 ). Higher sex hormone‐binding globulin decreased UF risk (beta‐per‐nmol/L=0.005, P =2.5×10 −3 ). No causal effect was found for BP. Conclusions Our study shows that UFs share substantial genetic basis with traits related to BP, obesity, diabetes, and migraine, a predominantly female vascular disease. We provide Mendelian randomization‐based evidence for central obesity, visceral fat traits, and sex‐steroid bioavailability as relevant risk factors for UFs.

Association Between Uterine Fibroids and Risk of Atherosclerotic Cardiovascular Disease

Background Uterine fibroids and atherosclerotic cardiovascular disease (ASCVD) share biological pathways, yet whether risk of ASCVD is different among those with fibroids compared with those without remains unexplored in large US cohorts with longitudinal data. This study assessed the association between uterine fibroids and risk of incident ASCVD. Methods A US population‐based cohort study was done using Optum’s de‐identified Clinformatics Data Mart Database (2000–2022). Follow‐up continued until an ASCVD event, disenrollment, incident fibroid diagnosis in controls, or June 30, 2022. Individuals with fibroids were exact age‐matched (1:5) to individuals without fibroids with an annual gynecologic claim. Incident ASCVD, a composite of coronary artery disease, cerebrovascular disease, and peripheral artery disease, was evaluated, including individual events (eg, myocardial infarction and ischemic stroke). Results Among 450 177 individuals with fibroids and 2 250 885 controls (mean age: 41 years, SD 6.3), the 1‐year and 10‐year cumulative incidence (95% CI) of ASCVD was 0.74% (0.71–0.77) and 5.42% (5.18–5.67) for the fibroid group versus 0.30% (0.29–0.31) and 3.00% (2.90–3.11) for controls. Adjusted analyses showed an increased ASCVD risk in the fibroid group (1‐year risk ratio: 2.47 [95% CI, 2.32–2.61]; 1‐year risk difference, 0.41% [95% CI, 0.40–0.47]; 10‐year risk ratio, 1.81 [95% CI, 1.66–1.96]; 10‐year risk difference, 2.40% [95% CI, 2.07, 2.77]. The increased risk was consistent for all individual components of ASCVD. Results were consistent across race and ethnicity and age subgroup analyses and sensitivity analyses addressing measurement error. Conclusions Uterine fibroids are associated with sustained increased ASCVD risks up to 10 years postdiagnosis, supporting targeted ASCVD prevention in this population.

Publisher

Ovid Technologies (Wolters Kluwer Health)

ISSN

2047-9980